» Articles » PMID: 31776854

LncRNA MYCNOS Facilitates Proliferation and Invasion in Hepatocellular Carcinoma by Regulating MiR-340

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2019 Nov 29
PMID 31776854
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) remains one of the most common and aggressive human cancers worldwide. Accumulating evidences indicate that non-coding RNAs are critical regulators implicated in various physiological processes including HCC development. Long non-coding RNA (lncRNA) MYCN opposite-strand (MYCNOS) was reported to be up-regulated in several human cancers, yet its role in HCC progression is still elusive. In the present study, MYCNOS was up-regulated in both HCC tissues and cell lines, and elevated MYCNOS expression was correlated to shorter survival time of HCC patients. We knocked down MYCNOS expression using short hairpin RNAs specifically targeting MYCNOS. MYCNOS knockdown significantly inhibited proliferation in HCC cells in vitro accompanied by exacerbated cell apoptosis; it also suppressed tumor growth in mouse model in vivo. Besides, the migration and invasion of HCC cells were remarkably inhibited after MYCNOS knockdown. In addition, MYCNOS acted as a negative regulator of miR-340 in HCC cells, and all effects of MYCNOS knockdown were abrogated by further miR-340 inhibition. We also discovered that oncogene phosphatidylinositol-3, 4, 5-trisphosphate-dependent Rac exchange factor 2 (PREX2) was a downstream target of miR-340, and PREX2 expression was positively correlated to that of MYCNOS in HCC tissues. In conclusion, our findings demonstrated that MYCNOS knockdown inhibited HCC progression through regulating miR-340.

Citing Articles

Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15.

Niu Y, Tang Y, Ma F, Zhou X, Chen Y, Wang Y Oncogene. 2024; 44(4):255-268.

PMID: 39511411 PMC: 11746145. DOI: 10.1038/s41388-024-03202-1.


Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons.

Goyal H, Parwani S, Kaur J Cell Death Discov. 2024; 10(1):451.

PMID: 39448589 PMC: 11502918. DOI: 10.1038/s41420-024-02200-2.


The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside.

Jin X, Huang C, Tian Y Clin Exp Med. 2024; 24(1):146.

PMID: 38960924 PMC: 11222271. DOI: 10.1007/s10238-024-01418-9.


Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.

Ye L, Tong X, Pan K, Shi X, Xu B, Yao X Front Pharmacol. 2024; 15:1351929.

PMID: 38895621 PMC: 11185051. DOI: 10.3389/fphar.2024.1351929.


Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.

Vercouillie N, Ren Z, Terras E, Lammens T Int J Mol Sci. 2024; 25(11).

PMID: 38891878 PMC: 11171840. DOI: 10.3390/ijms25115690.


References
1.
Wapinski O, Chang H . Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6):354-61. DOI: 10.1016/j.tcb.2011.04.001. View

2.
Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T . Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene. 2003; 22(19):3007-14. DOI: 10.1038/sj.onc.1206401. View

3.
OBrien E, Selfe J, Martins A, Walters Z, Shipley J . The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. BMC Cancer. 2018; 18(1):217. PMC: 5822637. DOI: 10.1186/s12885-018-4129-8. View

4.
Martens-Uzunova E, Bottcher R, Croce C, Jenster G, Visakorpi T, Calin G . Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2013; 65(6):1140-51. DOI: 10.1016/j.eururo.2013.12.003. View

5.
Wu Z, Wu Q, Wang C, Wang X, Huang J, Zhao J . miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer. 2011; 117(13):2842-52. DOI: 10.1002/cncr.25860. View